SHP-141C in Plaque Type Psoriasis

NCT01646567 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Type Psoriasis

Interventions

DRUG: SHP-141C
DRUG: Placebo to SHP-141C
DRUG: Betamethasone Valerate
DRUG: Calcipotriol

Sponsor

TetraLogic Pharmaceuticals